Company / Return on Assets (ROA)
Senti Biosciences Holdings, Inc. Return on Assets (ROA) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-103.1%
FY2025
5-year range
-103.1% / -30.6%
FY2022-FY2025
Trend
-41.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has declined for 3 consecutive years, from -30.6% in FY2022 to -103.1% in FY2025.
Based on SEC 10-K filings.
-103.1% in FY2025 with a 3-year CAGR of -72.5%.
Declined from -48.7% to -103.1% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -72.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Senti Biosciences Holdings, Inc.'s return on assets (roa) has declined for 3 consecutive years.
- In FY2025, return on assets (roa) decreased 41.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -103.1% | -41.9% |
| FY2024 | -72.6% | -49.1% |
| FY2023 | -48.7% | -59.2% |
| FY2022 | -30.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026